Semenogelin I and II, the predominant human seminal plasma proteins, are also expressed in non-genital tissues
about
sameAs
A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissueSemenogelins I and II bind zinc and regulate the activity of prostate-specific antigenThe evolution of a genetic locus encoding small serine proteinase inhibitorsEvaluation of semen presumptive tests for use at crime scenes.Proteomic changes of alveolar lining fluid in illnesses associated with exposure to inhaled non-infectious microbial particles.Use of the dye stain assay and ultraviolet light test for assessing vaginal insertion of placebo-filled applicators before and after sexLevels of semenogelin in human spermatozoa decrease during capacitation: involvement of reactive oxygen species and zinc.Body fluid identification by mass spectrometry.Upregulation of miR-96 enhances cellular proliferation of prostate cancer cells through FOXO1Analysis of prostate-specific antigen transcripts in chimpanzees, cynomolgus monkeys, baboons, and African green monkeys.Contemporary evidence on the physiological role of reactive oxygen species in human sperm function.INSTRUMENTS OF HIGH RISK SEXUAL BEHAVIOR ASSESSMENT: A SYSTEMATIC REVIEW.Reproduction and immunity-driven natural selection in the human WFDC locus.An evaluation of methods to improve the reporting of adherence in a placebo gel trial in Andhra Pradesh, India.Semenogelin I expression in myeloma cells can be upregulated pharmacologically.An aberrant prostate antigen-specific immune response causes prostatitis in mice and is associated with chronic prostatitis in humans.Core promoter sequence of SEMG I spans between the two putative GATA-1 binding domains and is responsive to IL-4 and IL-6 in myeloma cells.miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.Seminal Tract Amyloidosis: Synchronous Amyloidosis of the Seminal Vesicles, Deferent Ducts and Ejaculatory Ducts.miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients.Expression of semenogelins I and II and its prognostic significance in human prostate cancer.Semenogelin I promotes prostate cancer cell growth via functioning as an androgen receptor coactivator and protecting against zinc cytotoxicity.Semenogelins in the human retina: Differences in distribution and content between AMD and normal donor tissues.Occurrence and reproductive roles of hormones in seminal plasma.Duration of sexual abstinence: epididymal and accessory sex gland secretions and their relationship to sperm motility.A peptide from human semenogelin I self-assembles into a pH-responsive hydrogel.Extended specificity studies of mRNA assays used to infer human organ tissues and body fluids.Evaluation of Human Semenogelin Membrane Strip Test for Species Cross-reactivity in Dogs.Expression of the prolactin-inducible protein (PIP/GCDFP15) gene in benign epithelium and adenocarcinoma of the prostate.Developmental validation of RSID™-Semen: a lateral flow immunochromatographic strip test for the forensic detection of human semen.Ejaculate fractions of asthenozoospermic and teratozoospermic patients have differences in the sperm DNA integrity.Seminal plasma protein in renal cell carcinoma: expression of semenogelin I is a predictor for cancer progression and prognosis.
P2860
Q24299110-4DFCCA2F-8762-4FFC-8DF6-819EE1544C17Q24316982-5BE23E4F-0B7C-445F-A21F-1A77952ABAE4Q24682006-7E619F01-3EF6-408A-B529-99011576689AQ33905713-2F2BFA7D-CA56-4A4A-81EA-124C65CA3C4CQ33916460-6766D5CB-4750-451A-AD5F-CC7C848CA950Q34084215-4CBD452E-C431-4037-B6D8-3B3984430B04Q34117356-4D6DCC65-E0E7-4DC6-A4CE-CA511A633CB5Q34633625-844C156D-4B50-4D35-B6DF-154C58146BB8Q34951635-15188429-8C54-4D73-A5C0-D328B14A47C9Q35147686-8B007E4E-D153-4563-ADF3-84EE31A5C47DQ35236627-053CB1D0-CCEC-4E62-92E9-80F89A442BF4Q35980204-660B3985-FD46-4209-BB2B-278EC1F95573Q36702004-751C9EB8-F357-441A-A336-3931A0EFD4A5Q36906506-6D22D966-94E0-45F6-842C-C2D69896DC45Q37042374-36418FEF-BDEE-42F7-9762-ED61A21078AFQ37241405-22B29AD4-230F-400B-8233-3DFED89E1BF9Q38289543-3217ABE2-413A-4A80-B65E-8899AE55EC5CQ38875539-0E5EB1AD-446B-49FA-9E05-02D110070DC6Q39093187-E9A1FC68-282B-4E10-A497-20921131C56FQ39168818-98C5BCA2-E766-4DCA-BA48-7C3C2C961725Q39545335-3B03B03F-D00E-4347-A7AB-61A003B7C1F1Q39608321-11B861E4-A37F-49BB-BB9B-436F44D6EDBDQ41788726-01D7C5A1-1034-4905-A260-67E74EDDC3CFQ42377478-E8F3214A-122C-4336-9B02-34FED5796A53Q45154692-D8ECCAD8-E1AF-4F1A-B745-91233ADE9DD3Q46128522-952D2C73-F6C0-4D92-91BA-E403CB47B862Q46313284-993D045E-FB33-4B9B-9D4D-5A77527592B5Q46638861-AC56A5EB-D9D3-44C7-B57A-D5C79536B577Q47383280-79E8532D-AADC-4490-95B5-D346AC06C0F1Q51829513-5BBCCBAD-3B0A-47A3-A158-1CFFAB1BCCC0Q53242406-B3187BCB-D9AF-4EBB-8E7E-A4B51C6B5A00Q54198864-485612DA-F493-4E30-9B36-B21AB1341D83
P2860
Semenogelin I and II, the predominant human seminal plasma proteins, are also expressed in non-genital tissues
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Semenogelin I and II, the pred ...... pressed in non-genital tissues
@ast
Semenogelin I and II, the pred ...... pressed in non-genital tissues
@en
Semenogelin I and II, the pred ...... pressed in non-genital tissues
@nl
type
label
Semenogelin I and II, the pred ...... pressed in non-genital tissues
@ast
Semenogelin I and II, the pred ...... pressed in non-genital tissues
@en
Semenogelin I and II, the pred ...... pressed in non-genital tissues
@nl
prefLabel
Semenogelin I and II, the pred ...... pressed in non-genital tissues
@ast
Semenogelin I and II, the pred ...... pressed in non-genital tissues
@en
Semenogelin I and II, the pred ...... pressed in non-genital tissues
@nl
P2093
P356
P1476
Semenogelin I and II, the pred ...... pressed in non-genital tissues
@en
P2093
A Yvonne Olsson
Ake Lundwall
Anders Bjartell
P304
P356
10.1093/MOLEHR/8.9.805
P407
P50
P577
2002-09-01T00:00:00Z